Literature DB >> 25376119

Neuropathic ocular pain: an important yet underevaluated feature of dry eye.

A Galor1, R C Levitt2, E R Felix3, E R Martin4, C D Sarantopoulos5.   

Abstract

Dry eye has gained recognition as a public health problem given its prevalence, morbidity, and cost implications. Dry eye can have a variety of symptoms including blurred vision, irritation, and ocular pain. Within dry eye-associated ocular pain, some patients report transient pain whereas others complain of chronic pain. In this review, we will summarize the evidence that chronicity is more likely to occur in patients with dysfunction in their ocular sensory apparatus (ie, neuropathic ocular pain). Clinical evidence of dysfunction includes the presence of spontaneous dysesthesias, allodynia, hyperalgesia, and corneal nerve morphologic and functional abnormalities. Both peripheral and central sensitizations likely play a role in generating the noted clinical characteristics. We will further discuss how evaluating for neuropathic ocular pain may affect the treatment of dry eye-associated chronic pain.

Entities:  

Mesh:

Year:  2014        PMID: 25376119      PMCID: PMC4366454          DOI: 10.1038/eye.2014.263

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  122 in total

1.  Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.

Authors:  S Shimmura; J Shimazaki; K Tsubota
Journal:  Cornea       Date:  1999-07       Impact factor: 2.651

2.  Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease.

Authors:  Marisa Tesón; María J González-García; Alberto López-Miguel; Amalia Enríquez-de-Salamanca; Vicente Martín-Montañez; María Jesús Benito; María Eugenia Mateo; Michael E Stern; Margarita Calonge
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

3.  The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

Authors:  Polyxane Mertzanis; Linda Abetz; Krithika Rajagopalan; Derek Espindle; Robin Chalmers; Christopher Snyder; Barbara Caffery; Timothy Edrington; Trefford Simpson; J Daniel Nelson; Carolyn Begley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

4.  Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery.

Authors:  Maria Soledad Cortina; Jiucheng He; Tiffany Russ; Nicolas G Bazan; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

5.  Omega-3 fatty acids for neuropathic pain: case series.

Authors:  Gordon D Ko; Nathaniel Benjamin Nowacki; Leigh Arseneau; Melanie Eitel; Annie Hum
Journal:  Clin J Pain       Date:  2010-02       Impact factor: 3.442

Review 6.  Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

Authors:  A J Lee; J Lee; S-M Saw; G Gazzard; D Koh; D Widjaja; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

7.  Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain.

Authors:  Wei Guo; Hu Wang; Mineo Watanabe; Kohei Shimizu; Shiping Zou; Stacey C LaGraize; Feng Wei; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

8.  Ocular surface-evoked Fos-like immunoreactivity is enhanced in trigeminal subnucleus caudalis by prior exposure to endotoxin.

Authors:  K Okamoto; D F Bereiter; A Tashiro; D A Bereiter
Journal:  Neuroscience       Date:  2008-12-16       Impact factor: 3.590

9.  Evaluation of the psychometric properties of the revised short-form McGill Pain Questionnaire.

Authors:  Travis I Lovejoy; Dennis C Turk; Benjamin J Morasco
Journal:  J Pain       Date:  2012-12       Impact factor: 5.820

Review 10.  The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment.

Authors:  Joseph Pergolizzi; Karsten Ahlbeck; Dominic Aldington; Eli Alon; Flaminia Coluzzi; Albert Dahan; Frank Huygen; Magdalena Kocot-Kępska; Ana Cristina Mangas; Philippe Mavrocordatos; Bart Morlion; Gerhard Müller-Schwefe; Andrew Nicolaou; Concepción Pérez Hernández; Patrick Sichère; Michael Schäfer; Giustino Varrassi
Journal:  Curr Med Res Opin       Date:  2013-07-03       Impact factor: 2.580

View more
  65 in total

1.  Bulbar conjunctival microvascular responses in dry eye.

Authors:  Wan Chen; Hatim Ismail M Batawi; Jimmy R Alava; Anat Galor; Jin Yuan; Constantine D Sarantopoulos; Allison L McClellan; William J Feuer; Roy C Levitt; Jianhua Wang
Journal:  Ocul Surf       Date:  2016-12-29       Impact factor: 5.033

2.  Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women.

Authors:  Nan Jiang; Lin-Hong Ye; Lei Ye; Jing Yu; Qi-Chen Yang; Qing Yuan; Pei-Wen Zhu; Yi Shao
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

Review 3.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 4.  Therapeutic Strategies to Treat Dry Eye in an Aging Population.

Authors:  Nisreen S Ezuddin; Karam A Alawa; Anat Galor
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

5.  Cyclosporine in ocular surface inflammation.

Authors:  P Hossain
Journal:  Eye (Lond)       Date:  2017-02-17       Impact factor: 3.775

Review 6.  [Novel current and future therapy options for treatment of dry eye disease].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

7.  Understanding the true burden of dry eye disease.

Authors:  Anat Galor; Roy C Levitt; Elizabeth R Felix; Constantine D Sarantopoulos
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

8.  Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain.

Authors:  M Cuneyt Ozmen; Gabriela Dieckmann; Stephanie M Cox; Ramy Rashad; Rumzah Paracha; Nedda Sanayei; Melina I Morkin; Pedram Hamrah
Journal:  Ocul Surf       Date:  2020-08-27       Impact factor: 5.033

Review 9.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

10.  Patients with more severe symptoms of neuropathic ocular pain report more frequent and severe chronic overlapping pain conditions and psychiatric disease.

Authors:  Ashley M Crane; Roy C Levitt; Elizabeth R Felix; Konstantinos D Sarantopoulos; Allison L McClellan; Anat Galor
Journal:  Br J Ophthalmol       Date:  2016-04-29       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.